CYTOEXPLORE
Live / Registered — Registered (as of 03 Sept 2024)
What this means for you
Registered since 03 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97671039
- Registration number
- 7496756
- Mark type
- Stylized text
- Filed
- 10 Nov 2022
- Published for opposition
- 03 Oct 2023
- Registered
- 03 Sept 2024
- Attorney of record
- Henry G. Chow
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical use; Chemical reagents for medical or veterinary purposes; Cultures of microorganisms for medical or veterinary use; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic preparations for medical purposes; Immunoassay reagents for medical use; Medical diagnostic reagents; Reagent paper for medical or veterinary purposes; Reagent paper for medical purposes; Reagents for medical use; Stem cells for medical purposes; Veterinary diagnostic reagents
Owner
- LiqBio biomedical company limited, New Taipei City,, TW
- LiqBio biomedical company limited, New Taipei City,, TW
- LiqBio biomedical company limited, New Taipei City,, TW
Prosecution history
- 03 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 30 Jul 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Jul 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Jun 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 16 May 2024 — USE AMENDMENT FILED
- 24 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 28 Nov 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Oct 2023 — PUBLISHED FOR OPPOSITION
- 13 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Aug 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Aug 2023 — ASSIGNED TO EXAMINER
- 30 Nov 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED